Dr. Olivier Delattre is MD-PhD, trained in pediatric oncology. He heads the SIREDO Pediatric Oncology Center at Institut Curie which gathers clinicians and scientists to accelerate the development of new therapeutic strategies for pediatric cancers. His lab identified some key genetic abnormalities in Ewing sarcoma, rhabdoid tumors, neuroblastoma as well as in various sarcomas. His lab investigates the functional consequences of these alterations in tumor development and has established animal models. His current fields of interest are the study of genetic alterations associated with pediatric cancers, the study of the pediatric cancer cells-of-origin and the investigation of mechanisms of phenotypic plasticity.
Dr Delattre has published more than 400 manuscripts with an H-index of 104. He received numerous awards including the ARC Leopold Griffuel award in 2016, the Inserm Grand Prix in 2022 and the AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research in 2023. He is an elected member of EMBO and of Academia Europea.
